House Bill 6102
116th Congress(2019-2020)
VALID Act of 2020
Introduced
Introduced in House on Mar 5, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6102
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020
This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
March 5, 2020
03/05/2020
Referred to the House Committee on Energy and Commerce.
03/05/2020
Introduced in House
Public Record
Record Updated
Feb 8, 2022 11:16:10 PM